McKesson Corporation (MCK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for McKesson Corporation (MCK:NYSE), powered by AI.

Current Price
$888.56
P/E Ratio
23.1
Market Cap
109.8B
Sector
Healthcare
What is the McKesson Corporation stock price forecast?

McKesson Corporation is currently trading at $888.56. View real-time AI analysis on Alpha Lenz.

What is McKesson Corporation insider trading activity?

View the latest insider trading data for McKesson Corporation on Alpha Lenz.

What is McKesson Corporation's P/E ratio?

McKesson Corporation's P/E ratio is 23.1.

McKesson Corporation

NYSE · MCK
$888.56-0.94(-0.11%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about McKesson Corporation's future dividend policy...
Alpha Chat Insight

McKesson Corporation trades at a P/E of 23.1 (fair value) with modest ROE of -224.3%. 3Y revenue CAGR of 13.4% highlights clear growth momentum.

Ask for details

Company Overview

McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.

CEOMr. Brian S. Tyler Ph.D.
SectorHealthcare
IndustryMedical Distribution
Employees43,000

Company Statistics

FY 2026

Profile

$109.83BMarket Cap
$403.43BRevenue
0.00Shares Out
43,000Employees

Margins

3.61%Gross
1.84%EBITDA
1.60%Operating
1.54%Pre-Tax
1.26%Net

Valuation

23.06P/E
-50.56P/B
0.27EV/Sales
15.64EV/EBITDA
20.30P/FCF

Growth (CAGR)

13.39%Rev 3Yr
11.11%Rev 5Yr
12.10%Op Inc 3Yr
14.36%Op Inc 5Yr
11.06%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

6.48%ROA
-224.31%ROE
8.19%ROIC

Financial Health

$3.98BCash & Cash Equivalents
$79.18BNet Debt
-9970.86%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

McKesson Corporation (ticker: MCK) is a company listed on NYSE in the Healthcare sector (Medical Distribution). It has approximately 43,000 employees. Market cap is $109.8B.

The current price is $888.56 with a P/E ratio of 23.06x and P/B of -50.56x.

ROE is -224.31% and operating margin is 1.60%. Annual revenue is $403.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
McKesson Corporation (MCK) Stock Forecast 2026 $888.56 — Price, Financials & Analyst Targets | Alpha Lenz